Application of biomarker in preparation or screening of liver cancer diagnostic reagent
A biomarker, a technology for cancer diagnosis, applied in the field of biomarkers in the preparation or screening of diagnostic reagents for liver cancer
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0122] The kit provided in this embodiment comprises:
[0123] Trizol lysate (Invitrogen, 15596-026);
[0124] RNAse-free homogenizer;
[0125] RNAse-free 1.5ml tube;
[0126] Chloroform;
[0127] isopropanol;
[0128] Washing solution (75% ethanol prepared with RNAse-free water);
[0129] RNAse-free water;
[0130] Reverse transcription reagent mixture (10 μL / tube, TAKARA, RR047A);
[0131] Q-PCR reagent mix (TAKARA, 639676);
[0132] Primer diluent (aqueous solution containing primers).
[0133] The operation method is as follows:
[0134] 1. Tumor sample preparation: For patients with multiple liver cancer foci, a piece of tumor (50 mg / part) was taken from each foci, and a total of 3 foci were taken; for patients with less than 3 liver cancer foci, random Take 3 tumor blocks (50 mg / part); the tumor tissues are labeled as HCC1, HCC2, HCC3. Take 3 pieces of paracancerous tissues randomly (50 mg / part), and mark Nor1, Nor2, Nor3.
[0135] 2. Cut the tissue as small a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com